Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers.

Labidi-Galy SI, de La Motte Rouge T, Derbel O, Wolfer A, Kalbacher E, Olivier T, Combes JD, Heimgartner-Hu K, Tredan O, Guevara H, Heudel PE, Reverdy T, Bazan F, Heinzelmann-Schwarz V, Fehr M, de Castelbajac V, Vaflard P, Crivelli L, Bonadona V, Viassolo V, Buisson A, Golmard L, Rodrigues M, Ray-Coquard I.

Gynecol Oncol. 2019 Oct 8. pii: S0090-8258(19)31528-8. doi: 10.1016/j.ygyno.2019.09.008. [Epub ahead of print]

PMID:
31604666
2.

A rare case of right lower quadrant pain.

Teiga E, Radosevic A, Sánchez J, Busto M, Aguilar G, Maiques J, Flores D, Zugazaga A, Beltran JG, Bazán F.

BJR Case Rep. 2018 Oct 31;5(2):20170024. doi: 10.1259/bjrcr.20170024. eCollection 2019 Jun.

3.

Establishment of a Gonococcal Antimicrobial Surveillance Programme, in Accordance With World Health Organization Standards, in Côte d'Ivoire, Western Africa, 2014-2017.

Yéo A, Kouamé-Blavo B, Kouamé CE, Ouattara A, Yao AC, Gbedé BD, Bazan F, Faye-Ketté H, Dosso M, Wi T, Unemo M.

Sex Transm Dis. 2019 Mar;46(3):179-184. doi: 10.1097/OLQ.0000000000000943.

PMID:
30461598
4.

[Prevalence and management of pain in patients with metastatic cancer in Franche-Comté].

Dénommé F, Kroemer M, Montcuquet P, Nallet G, Thiery-Vuillemin A, Bazan F, Mouillet G, Villanueva C, Demarchi M, Stein U, Almotlak H, Chaigneau L, Curtit E, Meneveau N, Maurina T, Dobi E, Hon TN, Cals L, Mansi L, Verlut C, Pana-Katatali H, Caubet M, Paillard MJ, Limat S, Pivot X, Nerich V.

Bull Cancer. 2016 Oct;103(10):849-860. doi: 10.1016/j.bulcan.2016.08.007. Epub 2016 Sep 29. French.

PMID:
27692731
5.

Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian Cancer.

Mansi L, Demarchi M, Bazan F, Delroeux D, Chaigneau L, Thiery-Vuillemin A, Bernhard S, Lakkis Z, Nerich V, Pivot X, Kalbacher E.

Int J Gynecol Cancer. 2016 Feb;26(2):261-7. doi: 10.1097/IGC.0000000000000592. Erratum in: Int J Gynecol Cancer. 2016 May;26(4):807. Lakkis, Zaehr [corrected to Lakkis, Zaher].

PMID:
26807562
6.

IMAGES IN CLINICAL MEDICINE. Pylephlebitis as a Complication of Diverticulitis.

Bazan F, Busto M.

N Engl J Med. 2015 Dec 3;373(23):2270. doi: 10.1056/NEJMicm1501584. No abstract available.

7.

[Efficacy, safety and cost of eribulin in patients with metastatic breast cancer].

Paillard MJ, Curtit E, Dobi E, Mansi L, Bazan F, Villanueva C, Chaigneau L, Montcuquet P, Meneveau N, Thiery-Vuillemin A, Nerich V, Pivot X.

Bull Cancer. 2015 Sep;102(9):737-48. doi: 10.1016/j.bulcan.2015.03.021. Epub 2015 May 26. French.

PMID:
26022285
8.

In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?

Pivot X, Mansi L, Chaigneau L, Montcuquet P, Thiery-Vuillemin A, Bazan F, Dobi E, Sautiere JL, Rigenbach F, Algros MP, Butler S, Jamshidian F, Febbo P, Svedman C, Paget-Bailly S, Bonnetain F, Villanueva C.

Oncologist. 2015 Apr;20(4):344-50. doi: 10.1634/theoncologist.2014-0198. Epub 2015 Mar 20.

9.

[Economic assessment of the routine use of Oncotype DX® assay for early breast cancer in Franche-Comte region].

Nerich V, Curtit E, Bazan F, Montcuquet P, Villanueva C, Chaigneau L, Cals L, Méneveau N, Dobi E, Altmotlak H, Algros MP, Choulot MJ, Nallet G, Limat S, Mansion S, Pivot X.

Bull Cancer. 2014 Jul-Aug;101(7-8):681-9. doi: 10.1684/bdc.2014.1923. French.

PMID:
25091650
10.

Lithopedion.

Bazan F, Radosevic A, Aguilar G, Sanchez J.

Cir Esp. 2014 Oct;92(8):e45. doi: 10.1016/j.ciresp.2014.03.006. Epub 2014 May 23. English, Spanish. No abstract available.

PMID:
24862685
11.

Long-term follow-up of patients with metastatic breast cancer treated by trastuzumab: impact of institutions.

Fiteni F, Villanueva C, Bazan F, Perrin S, Chaigneau L, Dobi E, Montcuquet P, Cals L, Meneveau N, Nerich V, Limat S, Pivot X.

Breast. 2014 Apr;23(2):165-9. doi: 10.1016/j.breast.2013.12.003. Epub 2013 Dec 22.

PMID:
24368024
12.

[Imaging renal cell carcinoma].

Bazan F, Busto M.

Radiologia. 2014 Jan-Feb;56(1):61-75. doi: 10.1016/j.rx.2013.08.005. Epub 2013 Nov 21. Review. Spanish.

13.

Chemotherapy-induced secondary pneumothorax.

Bazan F, Vollmer I, Gayete A.

Arch Bronconeumol. 2014 Jan;50(1):44. doi: 10.1016/j.arbres.2013.06.007. Epub 2013 Oct 8. English, Spanish. No abstract available.

14.

Deep pelvic postprostatectomy pseudoaneurysm treated by transrectal ultrasound-guided thrombin injection.

Bazan F, Sanchez Parrilla J, Radosevic A, Aguilar G, Frances A, del Riego J, Busto Barreda M.

Cardiovasc Intervent Radiol. 2014 Apr;37(2):544-7. doi: 10.1007/s00270-013-0657-4. Epub 2013 Jun 5. Review. No abstract available.

PMID:
23737023
15.

Discordances in estrogen receptor status, progesterone receptor status, and HER2 status between primary breast cancer and metastasis.

Curtit E, Nerich V, Mansi L, Chaigneau L, Cals L, Villanueva C, Bazan F, Montcuquet P, Meneveau N, Perrin S, Algros MP, Pivot X.

Oncologist. 2013 Jun;18(6):667-74. doi: 10.1634/theoncologist.2012-0350. Epub 2013 May 30.

16.

Characterization of the guinea pig CMV gH/gL/GP129/GP131/GP133 complex in infection and spread.

Auerbach M, Yan D, Fouts A, Xu M, Estevez A, Austin CD, Bazan F, Feierbach B.

Virology. 2013 Jun 20;441(1):75-84. doi: 10.1016/j.virol.2013.03.008. Epub 2013 Apr 4.

17.

First-line bevacizumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimisation analysis.

Nerich V, Bazan F, Compagnat F, Dobi E, Villanueva C, Chaigneau L, Perrin S, Voidey A, Pivot X, Limat S.

Anticancer Res. 2012 Aug;32(8):3547-52.

PMID:
22843944
18.

Is extracapsular tumour spread a prognostic factor in patients with early breast cancer?

Dobi E, Bazan F, Dufresne A, Demarchi M, Villanueva C, Chaigneau L, Montcuquet P, Ivanaj A, Sautière JL, Maisonnette-Escot Y, Cals L, Algros MP, Woronoff AS, Pivot X.

Int J Clin Oncol. 2013 Aug;18(4):607-13. doi: 10.1007/s10147-012-0439-z. Epub 2012 Jul 5.

PMID:
22763660
19.

Extravasation of liposomal doxorubicin induces irritant reaction without vesicant injury.

Curtit E, Chaigneau L, Pauchot J, Nguyen T, Nerich V, Bazan F, Thiery-Vuillemin A, Demarchi M, Pivot X, Villanueva C.

Anticancer Res. 2012 Apr;32(4):1481-3.

PMID:
22493389
20.

Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapy.

Chaumard N, Limat S, Villanueva C, Nerich V, Fagnoni P, Bazan F, Chaigneau L, Dobi E, Cals L, Pivot X.

Breast. 2012 Aug;21(4):464-7. doi: 10.1016/j.breast.2011.10.009. Epub 2011 Nov 26.

PMID:
22123411
21.

Metastatic gallbladder adenocarcinoma with signet-ring cells: A case report.

Bazan F, Sanchez J, Aguilar G, Radosevic A, Busto M, Zuccarino F, Pijuan L, Risueño N.

J Med Case Rep. 2011 Sep 14;5:458. doi: 10.1186/1752-1947-5-458.

22.

[Follow-up in patients with early breast cancer].

Maurina T, Chaigneau L, Bazan F, Villanueva C, Thiery-Vuillemin A, Kalbacher E, Curtit E, Cals L, N'guyen T, Pivot X.

Bull Cancer. 2011 Oct;98(9):1091-106. doi: 10.1684/bdc.2011.1431. French.

23.

Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysis.

Thiery-Vuillemin A, Montange D, Kalbacher E, Maurina T, Nguyen T, Royer B, Bouchet S, Bazan F, Curtit E, Pivot X.

Ann Oncol. 2011 Sep;22(9):2152-4. doi: 10.1093/annonc/mdr343. No abstract available.

PMID:
21878429
24.

Cabazitaxel: a novel microtubule inhibitor.

Villanueva C, Bazan F, Kim S, Demarchi M, Chaigneau L, Thiery-Vuillemin A, Nguyen T, Cals L, Dobi E, Pivot X.

Drugs. 2011 Jul 9;71(10):1251-8. doi: 10.2165/11591390-000000000-00000. Review. Erratum in: Drugs. 2011 Sep 10;71(13):1720.

PMID:
21770474
25.

Phase II trial of paclitaxel and uracil--tegafur in metastatic breast cancer. TEGATAX trial.

Villanueva C, Chaigneau L, Dufresne A, Thierry Vuillemin A, Stein U, Demarchi M, Bazan F, N'guyen T, Pivot X.

Breast. 2011 Aug;20(4):329-33. doi: 10.1016/j.breast.2011.02.018. Epub 2011 Mar 24.

PMID:
21439823
26.

Norbin: A promising central nervous system regulator.

Wang H, Nong Y, Bazan F, Greengard P, Flajolet M.

Commun Integr Biol. 2010 Nov;3(6):487-90. doi: 10.4161/cib.3.6.12844. Epub 2010 Nov 1.

27.

Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour.

Lorgis V, Algros MP, Villanueva C, Chaigneau L, Thierry-Vuillemin A, Nguyen T, Demarchi M, Bazan F, Sautiere JL, Maisonnette-Lescot Y, Ringenbach F, Bontemps P, Pivot X.

Breast. 2011 Jun;20(3):284-7. doi: 10.1016/j.breast.2010.12.007. Epub 2011 Feb 1.

PMID:
21288720
28.

Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors.

Thiery-Vuillemin A, Dobi E, Nguyen T, Royer B, Montange D, Maurina T, Kalbacher E, Bazan F, Villanueva C, Demarchi M, Chaigneau L, Ivanaj A, Pivot X.

Anticancer Drugs. 2010 Nov;21(10):958-62. doi: 10.1097/CAD.0b013e32833fc0be.

PMID:
20856105
29.

Sequential taxane and anthracycline-containing neoadjuvant regimens: the sequential order impact.

Thiery-Vuillemin A, Llombart-Cussac A, Chaigneau L, Villanueva C, Bazan F, Montcuquet P, Maisonnette-Escot Y, Sautiere JL, Algros MP, Pivot X.

Breast. 2011 Feb;20(1):46-9. doi: 10.1016/j.breast.2010.07.001. Epub 2010 Aug 7.

PMID:
20692157
30.

Safety profile of new anticancer drugs.

Mansi L, Thiery-Vuillemin A, Nguyen T, Bazan F, Calcagno F, Rocquain J, Demarchi M, Villanueva C, Maurina T, Pivot X.

Expert Opin Drug Saf. 2010 Mar;9(2):301-17. doi: 10.1517/14740330903530663. Review.

PMID:
20175699
31.

Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.

Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM, Maecker H, O'Rourke K, Bazan F, Eastham-Anderson J, Yue P, Dornan D, Huang DC, Dixit VM.

Nature. 2010 Jan 7;463(7277):103-7. doi: 10.1038/nature08646. Epub 2009 Dec 20.

PMID:
20023629
32.

Response rates: a valuable signal of promising activity?

Pivot X, Thierry-Vuillemin A, Villanueva C, Bazan F.

Cancer J. 2009 Sep-Oct;15(5):361-5. doi: 10.1097/PPO.0b013e3181bd045f. Review.

PMID:
19826354
33.

Ixabepilone: a new active chemotherapy in the treatment of breast cancer.

Villanueva C, Vuillemin AT, Demarchi M, Bazan F, Chaigneau L, Pivot X.

Womens Health (Lond). 2009 Mar;5(2):115-21. doi: 10.2217/17455057.5.2.115. Review.

PMID:
19245349
34.

In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs).

Otto H, Reche PA, Bazan F, Dittmar K, Haag F, Koch-Nolte F.

BMC Genomics. 2005 Oct 4;6:139.

35.

The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse.

Glowacki G, Braren R, Firner K, Nissen M, Kühl M, Reche P, Bazan F, Cetkovic-Cvrlje M, Leiter E, Haag F, Koch-Nolte F.

Protein Sci. 2002 Jul;11(7):1657-70.

36.

Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.

Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt Rd R, Bazan F, Kastelein RA, Liu YJ.

Nat Immunol. 2002 Jul;3(7):673-80. Epub 2002 Jun 10.

PMID:
12055625
37.

ADP-ribosyltransferases: plastic tools for inactivating protein and small molecular weight targets.

Koch-Nolte F, Reche P, Haag F, Bazan F.

J Biotechnol. 2001 Dec 28;92(2):81-7. Review.

PMID:
11640979
38.

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.

Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ.

J Exp Med. 2001 Sep 17;194(6):863-9.

39.

NFATz: a novel rel similarity domain containing protein.

Pan S, Tsuruta R, Masuda ES, Imamura R, Bazan F, Arai K, Arai N, Miyatake S.

Biochem Biophys Res Commun. 2000 Jun 16;272(3):765-76.

PMID:
10860829
40.

Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.

Cacalano NA, Migone TS, Bazan F, Hanson EP, Chen M, Candotti F, O'Shea JJ, Johnston JA.

EMBO J. 1999 Mar 15;18(6):1549-58.

41.

IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB.

Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelein R, Bazan F, O'Garra A.

Immunity. 1997 Oct;7(4):571-81.

42.

Two novel human members of an emerging mammalian gene family related to mono-ADP-ribosylating bacterial toxins.

Koch-Nolte F, Haag F, Braren R, Kühl M, Hoovers J, Balasubramanian S, Bazan F, Thiele HG.

Genomics. 1997 Feb 1;39(3):370-6. Erratum in: Genomics 1999 Jan 1;55(1):130.

PMID:
9119374
43.

Use of the EST database resource to identify and clone novel mono(ADP-ribosyl)transferase gene family members.

Braren R, Firner K, Balasubramanian S, Bazan F, Thiele HG, Haag F, Koch-Nolte F.

Adv Exp Med Biol. 1997;419:163-8. Review.

PMID:
9193649
44.

ADP-ribosylation and early transcription regulation by bacteriophage T4.

Wilkens K, Tiemann B, Bazan F, Rüger W.

Adv Exp Med Biol. 1997;419:71-82. Review.

PMID:
9193638
45.

Uncovered: the family relationship of a T-cell-membrane protein and bacterial toxins.

Koch-Nolte F, Haag F, Kastelein R, Bazan F.

Immunol Today. 1996 Sep;17(9):402-5. Review. No abstract available.

PMID:
8854554
46.

Mouse T cell membrane proteins Rt6-1 and Rt6-2 are arginine/protein mono(ADPribosyl)transferases and share secondary structure motifs with ADP-ribosylating bacterial toxins.

Koch-Nolte F, Petersen D, Balasubramanian S, Haag F, Kahlke D, Willer T, Kastelein R, Bazan F, Thiele HG.

J Biol Chem. 1996 Mar 29;271(13):7686-93.

47.

The CD40 antigen and its ligand.

Banchereau J, Bazan F, Blanchard D, Brière F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S.

Annu Rev Immunol. 1994;12:881-922. Review.

PMID:
7516669
48.

Protein design on computers. Five new proteins: Shpilka, Grendel, Fingerclasp, Leather, and Aida.

Sander C, Vriend G, Bazan F, Horovitz A, Nakamura H, Ribas L, Finkelstein AV, Lockhart A, Merkl R, Perry LJ, et al.

Proteins. 1992 Feb;12(2):105-10.

PMID:
1603799
49.

[Treatment of scarlet fever with penicillin].

BAZAN F, CERONI R, HUBERMAN J.

Acta Pediatr Esp. 1951 Dec;9(108):1443-7. Undetermined Language. No abstract available.

PMID:
14902480
50.

[Considerations on 100 cases of whooping cough treated with streptomycin].

BAZAN F, SUJOY E, GEILER S.

Acta Pediatr Esp. 1951 Nov;9(107):1373-5. Undetermined Language. No abstract available.

PMID:
14894241

Supplemental Content

Support Center